# NAPRELAN
> **NDA020353** · New Drug Application · Sponsor: TWI PHARMS · Approved 1996-01-05
## Drug
- **FDA Application Number:** NDA020353
- **Application type:** New Drug Application
- **Brand name:** NAPRELAN
- **Generic name:** NAPROXEN SODIUM
- **Active ingredients:** NAPROXEN SODIUM
- **Dosage form:** TABLET, EXTENDED RELEASE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** TWI PHARMS
- **Manufacturer:** Upsher-Smith Laboratories, LLC
- **First approval:** 1996-01-05
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020353)
---
*AI Analytics · CC0 1.0*